| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 53.2125 | 57 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.1651 | 28 |
| GSM780709 | Untreated after 4 days (C3_1) | 44.393 | 24 |
| GSM780719 | Untreated after 4 days (C1_2) | 51.7239 | 53 |
| GSM780720 | Untreated after 4 days (C2_2) | 55.1041 | 60 |
| GSM780721 | Untreated after 4 days (C3_2) | 52.7779 | 56 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 53.0062 | 56 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 49.4616 | 47 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 49.2457 | 46 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 49.4325 | 47 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 49.8773 | 48 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.9617 | 37 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 51.466 | 53 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 57.3813 | 62 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 53.1103 | 56 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 49.2004 | 46 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.3718 | 43 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.5526 | 39 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 52.1201 | 54 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 49.164 | 46 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 50.5822 | 50 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 52.8043 | 56 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 50.5167 | 50 |